A20 () Deficiency in Myeloid Cells Protects against Influenza A Virus Infection

English version České info

The innate immune response provides the first line of defense against viruses and other pathogens by responding to specific microbial molecules. Influenza A virus (IAV) produces double-stranded RNA as an intermediate during the replication life cycle, which activates the intracellular pathogen recognition receptor RIG-I and induces the production of proinflammatory cytokines and antiviral interferon. Understanding the mechanisms that regulate innate immune responses to IAV and other viruses is of key importance to develop novel therapeutic strategies. Here we used myeloid cell specific A20 knockout mice to examine the role of the ubiquitin-editing protein A20 in the response of myeloid cells to IAV infection. A20 deficient macrophages were hyperresponsive to double stranded RNA and IAV infection, as illustrated by enhanced NF-κB and IRF3 activation, concomitant with increased production of proinflammatory cytokines, chemokines and type I interferon. In vivo this was associated with an increased number of alveolar macrophages and neutrophils in the lungs of IAV infected mice. Surprisingly, myeloid cell specific A20 knockout mice are protected against lethal IAV infection. These results challenge the general belief that an excessive host proinflammatory response is associated with IAV-induced lethality, and suggest that under certain conditions inhibition of A20 might be of interest in the management of IAV infections.

Vyšlo v časopise: A20 () Deficiency in Myeloid Cells Protects against Influenza A Virus Infection. PLoS Pathog 8(3): e32767. doi:10.1371/journal.ppat.1002570
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002570

Souhrn

Zdroje

1. KawaiTAkiraS 2010 The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11 373 384

2. TakeuchiOAkiraS 2010 Pattern recognition receptors and inflammation. Cell 140 805 820

3. YoneyamaMFujitaT 2009 RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227 54 65

4. TakaokaAWangZChoiMKYanaiHNegishiH 2007 DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 501 505

5. BurckstummerTBaumannCBlumlSDixitEDurnbergerG 2009 An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10 266 272

6. Fernandes-AlnemriTYuJWDattaPWuJAlnemriES 2009 AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458 509 513

7. HornungVAblasserACharrel-DennisMBauernfeindFHorvathG 2009 AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 514 518

8. UnterholznerLKeatingSEBaranMHoranKAJensenSB 2010 IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11 997 1004

9. KatoHSatoSYoneyamaMYamamotoMUematsuS 2005 Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 19 28

10. RehwinkelJTanCPGoubauDSchulzOPichlmairA 2010 RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140 397 408

11. Le GofficRPothlichetJVitourDFujitaTMeursE 2007 Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 178 3368 3372

12. BaumASachidanandamRGarcia-SastreA 2010 Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 107 16303 16308

13. LooYMFornekJCrochetNBajwaGPerwitasariO 2008 Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82 335 345

14. KatoHTakeuchiOSatoSYoneyamaMYamamotoM 2006 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 101 105

15. GitlinLBarchetWGilfillanSCellaMBeutlerB 2006 Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 103 8459 8464

16. Le GofficRBalloyVLagranderieMAlexopoulouLEscriouN 2006 Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2 e53

17. XuLGWangYYHanKJLiLYZhaiZ 2005 VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19 727 740

18. SethRBSunLEaCKChenZJ 2005 Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122 669 682

19. MeylanECurranJHofmannKMoradpourDBinderM 2005 Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 1167 1172

20. KawaiTTakahashiKSatoSCobanCKumarH 2005 IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6 981 988

21. MaelfaitJBeyaertR 2012 The emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol Mol Biol Rev (in press)

22. GackMUShinYCJooCHUranoTLiangC 2007 TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446 916 920

23. GaoDYangYKWangRPZhouXDiaoFC 2009 REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One 4 e5760

24. OshiumiHMiyashitaMInoueNOkabeMMatsumotoM 2010 The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8 496 509

25. OganesyanGSahaSKGuoBHeJQShahangianA 2006 Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439 208 211

26. HackerHRedeckeVBlagoevBKratchmarovaIHsuLC 2006 Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 204 207

27. KonnoHYamamotoTYamazakiKGohdaJAkiyamaT 2009 TRAF6 establishes innate immune responses by activating NF-κB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One 4 e5674

28. KayagakiNPhungQChanSChaudhariRQuanC 2007 DUBA: a deubiquitinase that regulates type I interferon production. Science 318 1628 1632

29. ZhangMWuXLeeAJJinWChangM 2008 Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem 283 18621 18626

30. FriedmanCSO'DonnellMALegarda-AddisonDNgACardenasWB 2008 The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 9 930 936

31. LiSZhengHMaoAPZhongBLiY 2010 Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J Biol Chem 285 4291 4297

32. YouFSunHZhouXSunWLiangS 2009 PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 10 1300 1308

33. NakhaeiPMespledeTSolisMSunQZhaoT 2009 The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog 5 e1000650

34. YuYHaywardGS 2010 The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33 863 877

35. BollandSGarcia-SastreA 2009 Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice. J Exp Med 206 1647 1651

36. ZhangMTianYWangRPGaoDZhangY 2008 Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Cell Res 18 1096 1104

37. LeeEGBooneDLChaiSLibbySLChienM 2000 Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289 2350 2354

38. WertzIEO'RourkeKMZhouHEbyMAravindL 2004 De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430 694 699

39. SkaugBChenJDuFHeJMaAChenZJ 2011 Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell 44 559 571

40. BooneDLTurerEELeeEGAhmadRCWheelerMT 2004 The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5 1052 1060

41. ShembadeNMaAHarhajEW 2010 Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327 1135 1139

42. HammerGETurerEETaylorKEFangCJAdvinculaR 2011 Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 12 1184 1193

43. ChuYVahlJCKumarDHegerKBertossiA 2010 B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 117 2227 2236

44. TavaresRMTurerEELiuCLAdvinculaRScapiniP 2010 The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33 181 191

45. VereeckeLBeyaertRvan LooG 2009 The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 30 383 391

46. HovelmeyerNReissigSXuanNTAdams-QuackPLukasD 2011 A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 41 595 601

47. KoolMvan LooGWaelputWDe PrijckSMuskensF 2011 The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35 82 96

48. MatmatiMJacquesPMaelfaitJVerheugenEKoolM 2011 A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 43 908 912

49. OnoseAHashimotoSHayashiSMaruokaSKumasawaF 2006 An inhibitory effect of A20 on NF-kappaB activation in airway epithelium upon influenza virus infection. Eur J Pharmacol 541 198 204

50. LinRYangLNakhaeiPSunQSharif-AskariE 2006 Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 281 2095 2103

51. WangYYLiLHanKJZhaiZShuHB 2004 A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-κB and ISRE and IFN-β promoter. FEBS Lett 576 86 90

52. SaitohTYamamotoMMiyagishiMTairaKNakanishiM 2005 A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol 174 1507 1512

53. YoneyamaMKikuchiMNatsukawaTShinobuNImaizumiT 2004 The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5 730 737

54. LinRMamaneYHiscottJ 2000 Multiple regulatory domains control IRF-7 activity in response to virus infection. J Biol Chem 275 34320 34327

55. SatoMSuemoriHHataNAsagiriMOgasawaraK 2000 Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13 539 548

56. VereeckeLSzeMMc GuireCRogiersBChuY 2010 Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J Exp Med 207 1513 1523

57. KatoHTakeuchiOMikamo-SatohEHiraiRKawaiT 2008 Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205 1601 1610

58. HemmiHTakeuchiOSatoSYamamotoMKaishoT 2004 The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 199 1641 1650

59. LinRHeylbroeckCPithaPMHiscottJ 1998 Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18 2986 2996

60. LandsmanLVarolCJungS 2007 Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol 178 2000 2007

61. LukacherAEBracialeVLBracialeTJ 1984 In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 160 814 826

62. BenderBSCroghanTZhangLSmallPAJr 1992 Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175 1143 1145

63. YoonHLeggeKLSungSSBracialeTJ 2007 Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection. J Immunol 179 391 399

64. La GrutaNLKedzierskaKStambasJDohertyPC 2007 A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85 85 92

65. HoltPGOliverJBilykNMcMenaminCMcMenaminPG 1993 Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 177 397 407

66. ThepenTVan RooijenNKraalG 1989 Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 170 499 509

67. TumpeyTMGarcia-SastreATaubenbergerJKPalesePSwayneDE 2005 Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79 14933 14944

68. TateMDPickettDLvan RooijenNBrooksAGReadingPC 2010 Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol 84 7569 7580

69. BeckerSQuayJSoukupJ 1991 Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 147 4307 4312

70. KumagaiYTakeuchiOKatoHKumarHMatsuiK 2007 Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27 240 252

71. TateMDIoannidisLJCrokerBBrownLEBrooksAG 2011 The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One 6 e17618

72. TateMDBrooksAGReadingPC 2008 The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir Res 9 57

73. SmallBADresselSALawrenceCWDrakeDR3rdStolerMH 2001 CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells. J Exp Med 194 1835 1846

74. HeroldSSteinmuellerMvon WulffenWCakarovaLPintoR 2008 Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 205 3065 3077

75. WareingMDLyonAInglisCGiannoniFCharoI 2007 Chemokine regulation of the inflammatory response to a low-dose influenza infection in CCR2−/− mice. J Leukoc Biol 81 793 801

76. DawsonTCBeckMAKuzielWAHendersonFMaedaN 2000 Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156 1951 1959

77. LinKLSuzukiYNakanoHRamsburgEGunnMD 2008 CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 180 2562 2572

78. XuLYoonHZhaoMQLiuJRamanaCV 2004 Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J Immunol 173 721 725

79. PeirisJSCheungCYLeungCYNichollsJM 2009 Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol 30 574 584

80. VerstrepenLVerhelstKvan LooGCarpentierILeySC 2010 Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol 80 2009 2020

81. ParvatiyarKBarberGNHarhajEW 2010 TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J Biol Chem 285 14999 15009

82. GaoLCoopeHGrantSMaALeySC 2011 ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. J Biol Chem 286 36592 36602

83. BarikS 2011 Intranasal Delivery of Antiviral siRNA. Methods Mol Biol 721 333 338

84. ClausenBEBurkhardtCReithWRenkawitzRForsterI 1999 Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8 265 277

85. ReedLJMuenchH 1938 A simple method of estimating fifty percent endpoints. Am J Hyg 27 493 497

86. HuffordMMKimTSSunJBracialeTJ 2011 Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med 208 167 180